NCT00946608View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Allergy
Interventions
DRUG

Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.)

DRUG

Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.)

DRUG

Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946608 - To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets | Biotech Hunter | Biotech Hunter